We'd all like to invest like the legendary Warren Buffett, turning thousands into millions or more. Buffett analyzes companies by calculating return on invested capital (ROIC) to help determine whether a company has an economic moat -- the ability to earn returns on its money above that money's cost.

ROIC is perhaps the most important metric in value investing. By determining a company's ROIC, you can see how well it's using the cash you entrust to it and whether it's creating value for you. Simply, it divides a company's operating profit by how much investment it took to get that profit. The formula is

ROIC = Net operating profit after taxes / Invested capital

See more about the nuances of the formula in further detail.

This one-size-fits-all calculation cuts out many of the legal accounting tricks (such as excessive debt) that managers use to boost earnings numbers, and it provides you with an apples-to-apples way to evaluate businesses, even across industries. The higher the ROIC, the more efficient the company uses capital.

Ultimately, we're looking for companies that can invest their money at rates that are higher than the cost of capital, which for most businesses is between 8% and 12%. Ideally, we want to see ROIC above 12%, at a minimum, and a history of increasing returns, or at least steady returns, which indicate some durability to the company's economic moat.

Let's take a look at Novartis (NYSE: NVS) and three of its industry peers, to see how efficiently they use cash. Here are the ROIC figures for each company over a few periods.

Company

TTM

1 Year Ago

3 Years Ago

5 Years Ago

Novartis 11.6% 9.9% 12.1% 13.3%
Pfizer (NYSE: PFE) 11.8% 8.8% 17.2% 16.7%
GlaxoSmithKline (NYSE: GSK) 28% 21.5% 25.3% 34.3%
Merck (NYSE: MRK) 13.9% 7.1% 19.7% 19.7%

Source: S&P Capital IQ.

Novartis' returns on invested capital are almost 2 percentage points below what they were five years ago. The other companies have also seen declines in their returns on invested capital over the same time period, though Glaxo managed to keep its numbers at a much higher level than its peers did.

Businesses with consistently high ROIC show that they're efficiently using capital. They also have the ability to treat shareholders well, because they can then use their extra cash to pay out dividends to us, buy back shares, or further invest in their franchise. And healthy and growing dividends are something that Warren Buffett has long loved.

So for more successful investments, dig a little deeper than the earnings headlines to find the company's ROIC. Add these companies to your Watchlist:

Jim Royal, Ph.D., owns no shares of any company mentioned here. Motley Fool newsletter services have recommended buying shares of Novartis, GlaxoSmithKline, and Pfizer. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.